Date | Insider | Price | Amount |
---|---|---|---|
12-8-2023 Insider Buy |
Dannielle Appelhans |
$1.79 CAGR » |
$14,339.11 8,000 shares |
12-4-2023 Insider Buy |
Dannielle Appelhans |
$1.50 CAGR » |
$18,000.00 12,000 shares |
9-16-2022 Insider Buy |
Charles A. Rowland Jr. |
$5.46 CAGR » |
$276,241.15 50,628 shares |
9-14-2022 Insider Buy |
Charles A. Rowland Jr. |
$5.22 CAGR » |
$127,403.94 24,384 shares |
3-10-2022 Insider Buy |
Donald William Nicholson |
$4.73 CAGR » |
$49,256.93 10,419 shares |
1-11-2021 Insider Buy |
Charles A. Rowland Jr. |
$24.50 CAGR » |
$499,996.00 20,408 shares |
1-11-2021 Insider Buy |
Donald William Nicholson |
$24.50 CAGR » |
$99,984.50 4,081 shares |
6-16-2020 Insider Buy |
Zone Healthcare Holdings, LLC |
$19.00 CAGR » |
$7,600,000.00 400,000 shares |
6-16-2020 Insider Buy |
William Seybold |
$19.00 CAGR » |
$7,600,000.00 400,000 shares |
6-16-2020 Insider Buy |
Invus Public Equities, L.P. >10% Owner |
$19.00 CAGR » |
$15,200,000.00 800,000 shares |
6-16-2020 Insider Buy |
Biomedical Innovation Master Investors (cayman) I. L.P. Wellington >10% Owner |
$19.00 CAGR » |
$20,900,000.00 1,100,000 shares |
6-16-2020 Insider Buy |
Casdin Capital, LLC >10% Owner |
$19.00 CAGR » |
$12,350,000.00 650,000 shares |
6-16-2020 Insider Buy |
Charles A. Rowland Jr. Director |
$19.00 CAGR » |
$570,000.00 30,000 shares |
6-16-2020 Insider Buy |
James E. Flynn >10% Owner |
$19.00 CAGR » |
$4,275,000.00 225,000 shares |
Also See: Institutional Holders of GBIO
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/11/2023 | |
End date: | 04/16/2024 | |
Start price/share: | $1.78 | |
End price/share: | $3.13 | |
Dividends collected/share: | $0.00 | |
Total return: | 75.84% | |
Annualized Gain: | 219.70% | |
Starting investment: | $10,000.00 | |
Ending investment: | $17,584.00 | |
Years: | 0.35 |
GBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent GBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GBIO
Free GBIO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the GBIO Insider Buying occurred are:
VERV Insider Buying |